array:21 [
  "pii" => "X2013251407020776"
  "issn" => "20132514"
  "doi" => " "
  "estado" => "S300"
  "fechaPublicacion" => "2007-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2007;27:23-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2896
    "formatos" => array:3 [
      "EPUB" => 207
      "HTML" => 1999
      "PDF" => 690
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699507020779"
      "issn" => "02116995"
      "doi" => " "
      "estado" => "S300"
      "fechaPublicacion" => "2007-02-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:23-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 13457
        "formatos" => array:3 [
          "EPUB" => 242
          "HTML" => 12456
          "PDF" => 759
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "23"
            "paginaFinal" => "29"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251407020776"
          "doi" => " "
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020779?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000001/v0_201502091327/X0211699507020779/v0_201502091327/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407020807"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:30-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3102
      "formatos" => array:3 [
        "EPUB" => 210
        "HTML" => 1975
        "PDF" => 917
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "USEFULNESS OF ORAL GLUCOSE TOLERANCE TEST (OGTT) IN OUTPUT PATIENTS WITH ADVANCED CHRONIC RENAL FAILURE (CRF)"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "30"
          "paginaFinal" => "37"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "IMPORTANCIA DEL TEST DE SOBRECARGA ORAL A LA GLUCOSA (TSOG) EN UNA CONSULTA ESPECÍFICA DE IRC AVANZADA ESTADIO IV Y V."
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702080X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702080X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020807?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020807/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407020823"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:12-22"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3199
      "formatos" => array:3 [
        "EPUB" => 202
        "HTML" => 2186
        "PDF" => 811
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "INTRAVENOUS CYCLOPHOSPHAMIDE IN LUPUS NEPHRITIS: TWENTY YEARS REDUCING DOSE"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "12"
          "paginaFinal" => "22"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "CICLOFOSFAMIDA INTRAVENOSA EN NEFRITIS LUPICA: VEINTE AÑOS REDUCIENDO DOSIS"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507020826"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020826?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020823?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020823/v0_201502091552/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "23"
        "paginaFinal" => "29"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL"
      ]
    ]
    "pdfFichero" => "P-E-S-A4333-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436396"
          "palabras" => array:4 [
            0 => "Aminoácidos"
            1 => "Glutamina"
            2 => "Insuficiencia renal"
            3 => "Cisplatino"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436397"
          "palabras" => array:4 [
            0 => "Amino acids"
            1 => "Glutamin"
            2 => "Renal failure"
            3 => "Cisplatin"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Glutamine is an amino acid (AA) whose mission is carrying nitrogen. Abnormalities in protein and AA metabolism has been observed in patients with acute renal failure. Several clinical trials had showed abnormalities in plasma AA and its elimination in uremic environment. Moreover, renal failure disturbs hepato-splachnic circulation of glutamin, tyrosine and proline. Cisplatin is a key drug in the chemotherapy pharmacology, and the nephrotoxicity due to tubular injury, is one of its most important side effects, which sometimes is irreversible and leads to substitutive renal treatment. The goal of this work is to find predictive factors of renal failure secondary to cisplatin. Fifty four patients treated with cisplatin were studied. The plasma AA concentration and another plasmatic and urine parameters were measured in three different days after each pulse of chemotherapy. Plasma AA modifications through the pulses and reabsortion percentages of everyone were analysed too. Significant differences were observed in 13 AA reabsortion percentages and 16 plasmatic concentration. Glutamin concentration through the pulses was higher in 13 patients, (24%) who presented renal failure (Plasmatic glutamin concentration higher than 1000 mM/L at the third day after cisplatin administration was highly predictive value about getting renal failure, with significant difference from patients with o normal renal function. Others parameters analysed did not rise significant predictive values, so as it was not found relation between hyperaminoaciduria and renal function. It is concluded that cisplatin leads to renal failure in a 24% of this patients. Glutamin, concentrations higher than 1000 mM/L at the third day after cisplatin administration have a high predictive value about getting renal failure&#59; so, it is suggested this could be a early marker of cisplatin nephrotoxicity before the serum creatinine is elevated, in order to get an early and suitable treatment of it. "
      ]
      "es" => array:1 [
        "resumen" => "La glutamina es un aminoácido encargado del transporte sanguíneo de nitrógeno. En pacientes que desarrollan insuficiencia renal se ha detectado alteración de los niveles plasmáticos de aminoácidos (AA) y alteración en su excreción urinaria. El cisplatino es un fármaco utilizado en quimioterapia, siendo la nefrotoxicidad uno de sus efectos secundarios más importantes. Con el objetivo de encontrar factores predictivos para el desarrollo de insuficiencia renal secundaria al cisplatino, se estudiaron 54 pacientes con diversos tumores en tratamiento con cisplatino, cuantificándose la concentración de AA y otros parámetros bioquímicos en plasma y en orina de 24 horas en tres días diferentes tras cada ciclo de quimioterapia. Se analizaron las variaciones de los AA plasmáticos a lo largo de los distintos ciclos de cisplatino y los porcentajes de reabsorción de cada uno de ellos. Se detectaron diferencias significativas a través de los ciclos en el porcentaje de reabsorción de 13 AA y en las concentraciones plasmáticas de 16. La concentración de glutamina a lo largo de los ciclos fue mayor en pacientes que desarrollaron insuficiencia renal. El valor de glutamina sérica > 1000 mM/L analizada el tercer día tras la administración de cisplatino fue altamente predictivo de desarrollar insuficiencia renal, con una diferencia significativa respecto a los pacientes que no la desarrollan. Se concluye que concentraciones superiores a 1000 mM/L de glutamina plasmática al tercer día tras la administración de cisplatino tienen un alto valor predictivo respecto al desarrollo de insuficiencia renal aguda. "
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/P-E-S-A4333-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE
CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL
M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho
Read
6379
Times
was read the article
2532
Total PDF
3847
Total HTML
Share statistics
 array:21 [
  "pii" => "X2013251407020776"
  "issn" => "20132514"
  "doi" => " "
  "estado" => "S300"
  "fechaPublicacion" => "2007-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2007;27:23-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2896
    "formatos" => array:3 [
      "EPUB" => 207
      "HTML" => 1999
      "PDF" => 690
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699507020779"
      "issn" => "02116995"
      "doi" => " "
      "estado" => "S300"
      "fechaPublicacion" => "2007-02-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:23-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 13457
        "formatos" => array:3 [
          "EPUB" => 242
          "HTML" => 12456
          "PDF" => 759
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "23"
            "paginaFinal" => "29"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251407020776"
          "doi" => " "
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020779?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000001/v0_201502091327/X0211699507020779/v0_201502091327/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407020807"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:30-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3102
      "formatos" => array:3 [
        "EPUB" => 210
        "HTML" => 1975
        "PDF" => 917
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "USEFULNESS OF ORAL GLUCOSE TOLERANCE TEST (OGTT) IN OUTPUT PATIENTS WITH ADVANCED CHRONIC RENAL FAILURE (CRF)"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "30"
          "paginaFinal" => "37"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "IMPORTANCIA DEL TEST DE SOBRECARGA ORAL A LA GLUCOSA (TSOG) EN UNA CONSULTA ESPECÍFICA DE IRC AVANZADA ESTADIO IV Y V."
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702080X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702080X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020807?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020807/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407020823"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:12-22"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3199
      "formatos" => array:3 [
        "EPUB" => 202
        "HTML" => 2186
        "PDF" => 811
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "INTRAVENOUS CYCLOPHOSPHAMIDE IN LUPUS NEPHRITIS: TWENTY YEARS REDUCING DOSE"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "12"
          "paginaFinal" => "22"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "CICLOFOSFAMIDA INTRAVENOSA EN NEFRITIS LUPICA: VEINTE AÑOS REDUCIENDO DOSIS"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507020826"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020826?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020823?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020823/v0_201502091552/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "23"
        "paginaFinal" => "29"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL"
      ]
    ]
    "pdfFichero" => "P-E-S-A4333-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436396"
          "palabras" => array:4 [
            0 => "Aminoácidos"
            1 => "Glutamina"
            2 => "Insuficiencia renal"
            3 => "Cisplatino"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436397"
          "palabras" => array:4 [
            0 => "Amino acids"
            1 => "Glutamin"
            2 => "Renal failure"
            3 => "Cisplatin"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Glutamine is an amino acid (AA) whose mission is carrying nitrogen. Abnormalities in protein and AA metabolism has been observed in patients with acute renal failure. Several clinical trials had showed abnormalities in plasma AA and its elimination in uremic environment. Moreover, renal failure disturbs hepato-splachnic circulation of glutamin, tyrosine and proline. Cisplatin is a key drug in the chemotherapy pharmacology, and the nephrotoxicity due to tubular injury, is one of its most important side effects, which sometimes is irreversible and leads to substitutive renal treatment. The goal of this work is to find predictive factors of renal failure secondary to cisplatin. Fifty four patients treated with cisplatin were studied. The plasma AA concentration and another plasmatic and urine parameters were measured in three different days after each pulse of chemotherapy. Plasma AA modifications through the pulses and reabsortion percentages of everyone were analysed too. Significant differences were observed in 13 AA reabsortion percentages and 16 plasmatic concentration. Glutamin concentration through the pulses was higher in 13 patients, (24%) who presented renal failure (Plasmatic glutamin concentration higher than 1000 mM/L at the third day after cisplatin administration was highly predictive value about getting renal failure, with significant difference from patients with o normal renal function. Others parameters analysed did not rise significant predictive values, so as it was not found relation between hyperaminoaciduria and renal function. It is concluded that cisplatin leads to renal failure in a 24% of this patients. Glutamin, concentrations higher than 1000 mM/L at the third day after cisplatin administration have a high predictive value about getting renal failure&#59; so, it is suggested this could be a early marker of cisplatin nephrotoxicity before the serum creatinine is elevated, in order to get an early and suitable treatment of it. "
      ]
      "es" => array:1 [
        "resumen" => "La glutamina es un aminoácido encargado del transporte sanguíneo de nitrógeno. En pacientes que desarrollan insuficiencia renal se ha detectado alteración de los niveles plasmáticos de aminoácidos (AA) y alteración en su excreción urinaria. El cisplatino es un fármaco utilizado en quimioterapia, siendo la nefrotoxicidad uno de sus efectos secundarios más importantes. Con el objetivo de encontrar factores predictivos para el desarrollo de insuficiencia renal secundaria al cisplatino, se estudiaron 54 pacientes con diversos tumores en tratamiento con cisplatino, cuantificándose la concentración de AA y otros parámetros bioquímicos en plasma y en orina de 24 horas en tres días diferentes tras cada ciclo de quimioterapia. Se analizaron las variaciones de los AA plasmáticos a lo largo de los distintos ciclos de cisplatino y los porcentajes de reabsorción de cada uno de ellos. Se detectaron diferencias significativas a través de los ciclos en el porcentaje de reabsorción de 13 AA y en las concentraciones plasmáticas de 16. La concentración de glutamina a lo largo de los ciclos fue mayor en pacientes que desarrollaron insuficiencia renal. El valor de glutamina sérica > 1000 mM/L analizada el tercer día tras la administración de cisplatino fue altamente predictivo de desarrollar insuficiencia renal, con una diferencia significativa respecto a los pacientes que no la desarrollan. Se concluye que concentraciones superiores a 1000 mM/L de glutamina plasmática al tercer día tras la administración de cisplatino tienen un alto valor predictivo respecto al desarrollo de insuficiencia renal aguda. "
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/P-E-S-A4333-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
DOI:
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 11 9 20
2024 October 54 80 134
2024 September 53 66 119
2024 August 58 109 167
2024 July 43 54 97
2024 June 50 47 97
2024 May 53 48 101
2024 April 44 39 83
2024 March 35 40 75
2024 February 42 44 86
2024 January 31 39 70
2023 December 26 22 48
2023 November 31 42 73
2023 October 63 41 104
2023 September 57 38 95
2023 August 30 25 55
2023 July 35 39 74
2023 June 35 22 57
2023 May 40 35 75
2023 April 21 25 46
2023 March 36 22 58
2023 February 23 19 42
2023 January 21 34 55
2022 December 40 31 71
2022 November 34 35 69
2022 October 26 38 64
2022 September 35 29 64
2022 August 41 38 79
2022 July 27 41 68
2022 June 33 41 74
2022 May 23 29 52
2022 April 25 40 65
2022 March 37 45 82
2022 February 32 39 71
2022 January 24 35 59
2021 December 36 47 83
2021 November 19 33 52
2021 October 23 41 64
2021 September 35 32 67
2021 August 17 29 46
2021 July 41 32 73
2021 June 18 20 38
2021 May 21 24 45
2021 April 45 41 86
2021 March 43 20 63
2021 February 23 21 44
2021 January 24 17 41
2020 December 14 7 21
2020 November 23 10 33
2020 October 10 11 21
2020 September 17 6 23
2020 August 32 9 41
2020 July 21 5 26
2020 June 13 7 20
2020 May 37 14 51
2020 April 22 14 36
2020 March 26 15 41
2020 February 28 11 39
2020 January 17 14 31
2019 December 27 18 45
2019 November 18 17 35
2019 October 11 8 19
2019 September 12 17 29
2019 August 9 15 24
2019 July 16 20 36
2019 June 17 21 38
2019 May 39 35 74
2019 April 38 40 78
2019 March 10 19 29
2019 February 9 17 26
2019 January 14 22 36
2018 December 15 27 42
2018 November 29 23 52
2018 October 23 22 45
2018 September 26 15 41
2018 August 15 9 24
2018 July 11 15 26
2018 June 12 22 34
2018 May 15 15 30
2018 April 8 11 19
2018 March 14 13 27
2018 February 4 8 12
2018 January 14 11 25
2017 December 12 15 27
2017 November 9 14 23
2017 October 16 14 30
2017 September 13 8 21
2017 August 22 12 34
2017 July 12 17 29
2017 June 12 15 27
2017 May 14 13 27
2017 April 20 9 29
2017 March 12 22 34
2017 February 16 10 26
2017 January 7 6 13
2016 December 32 11 43
2016 November 35 15 50
2016 October 31 20 51
2016 September 59 11 70
2016 August 97 10 107
2016 July 94 10 104
2016 June 96 0 96
2016 May 110 0 110
2016 April 96 0 96
2016 March 66 0 66
2016 February 70 0 70
2016 January 86 0 86
2015 December 98 0 98
2015 November 96 0 96
2015 October 74 0 74
2015 September 58 0 58
2015 August 61 0 61
2015 July 48 0 48
2015 June 32 0 32
2015 May 50 0 50
2015 April 13 0 13
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)